Patient and caregiver experiences with bladder instillations for neurogenic bladder after spinal cord injury
Interviews people with neurogenic bladder, and their caregivers, about gentamicin and Lactobacillus bladder treatments.
Key facts
- Who runs it
- Medstar Health Research Institute
- Where
- Washington D.C., United StatesSee the site
- Trial code
- Registry title
- Patient and Caregiver Perspectives on Intravesical Instillations for Urinary Symptoms
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 19 Jun 2025
- Expected to end
- Sept 2027
- Type of study
- Observational
- Record updated
- 5 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with neurogenic lower urinary tract dysfunction (bladder problems caused by nerve damage) who have used bladder instillations of Lactobacillus, gentamicin, or both. Their caregivers can also join. Participants take part in a one-hour interview.
- Age
- 18 years and older
- Sex
- All sexes
- Disease stage
- Patients must have a diagnosis of NLUTD, use a catheter long-term (at least 6 months, intermittent or indwelling), and live in the community. Caregivers must care for such a patient.
- Earlier treatment
- Patients must have used intravesical (put into the bladder) Lactobacillus, gentamicin, or both. Caregivers must have helped a patient use these.
Main reasons for not taking part
- Psychiatric or psychological conditions that affect the ability to give consent
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Criteria for patients:
- Age 18+
- Diagnosis of NLUTD
- Chronic catheter usage (minimum 6 months), either intermittent catheterization or indwelling catheter
- Community-dwelling
- Experience using intravesical Lactobacillus, gentamicin, or combination of the two; Criteria for caregivers:
- Age 18+
- Care for patient with diagnosis of NLUTD
- Care for patient who has used catheters chronically (minimum 6 months)
- Experience facilitating patients' use of intravesical Lactobacillus, gentamicin, or combination of the two
Who cannot take part
- Psychiatric or psychologic conditions impacting ability to consent
This trial is currently available in United States.
- MedStar National Rehabilitation HospitalWashington D.C., United StatesContact: Christopher Riegner, MPHTaking people
About the trial
What the trial wants to find out
The goal of this observational qualitative study is to learn about the experiences and perspectives of patients with neurogenic lower urinary tract dysfunction (NLUTD) and their caregivers regarding different types of intravesical instillations used for urinary health. The study aims to understand the perceived benefits, challenges, and opportunities related to Lactobacillus-only, gentamicin-only, and combined gentamicin-Lactobacillus instillations. The main question this study seeks to answer is:
Read full original descriptionShow less
1. Determine patient and caregivers' preferences, and overall experiences regarding intravesical therapeutics for urinary symptoms and UTI
Researchers will compare responses from four groups: participants who have used Lactobacillus-only instillations, gentamicin-only instillations, combined gentamicin-Lactobacillus instillations, and caregivers who have experience supporting instillations.
Participants will take part in a one-hour semi-structured interview and may be contacted for brief follow-up discussions to clarify findings. Interviews will be audio-recorded, transcribed, and analyzed using qualitative data software to identify themes related to treatment preferences and acceptability.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Intravesical Gentamicin Coupled With Lactobacillus Rhamnosus for Urinary Health- Early Career
- Plain-language title
- Patient and caregiver experiences with bladder instillations for neurogenic bladder after spinal cord injuryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 5 February 2026